Pricing Log in Create free account

Xencor, Inc. (XNCR) vs Zymeworks Inc. (ZYME)

Xencor, Inc. and Zymeworks Inc. are both Biotechnology companies. Xencor, Inc. and Zymeworks Inc. are of similar size ($1.8B and $1.8B). Xencor, Inc. grew revenue faster over the last twelve months: −28.6% against −69.8%. Xencor, Inc. has the higher net margin (−155.6% vs −404.0%) and the lower return on invested capital (−288.7% vs 0.00%). Across the 17 metrics below, Xencor, Inc. leads on 13 and Zymeworks Inc. on 4.

Valuation

Metric XNCR ZYME Biotechnology median
P/E n/m n/m 8.50
P/S 16.58 49.29 9.71
P/B 3.46 22.77 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 13.38 42.01 9.21
Earnings yield (9.46%) (8.06%) (33.15%)
Free cash flow yield (12.02%) (6.63%) (25.50%)

Profitability

Metric XNCR ZYME Biotechnology median
Gross margin 100.00% (246.66%) 65.16%
Operating margin (205.84%) (418.99%) 0.00%
Net margin (155.59%) (404.00%) 0.00%
Free cash flow margin (198.42%) (324.68%) 0.00%
Return on equity (29.07%) (72.31%) (56.36%)
Return on assets (20.36%) (37.25%) (48.04%)
Return on invested capital (288.71%) 0.00% 0.00%

Growth

Metric XNCR ZYME Biotechnology median
Revenue growth (TTM) (28.56%) (69.78%) 6.02%
EPS growth (last fiscal year) 65.36% 33.33% 30.26%
Revenue growth, 5-year CAGR 0.47% 22.16% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric XNCR ZYME Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.39 6.32 4.72
Net debt to EBITDA 2.51 2.81 0.96

Dividend

Metric XNCR ZYME Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric XNCR ZYME Biotechnology median
Market cap 1.78b 1.84b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack